Institute for the Advancement of Community Pharmacy Inc
Nonprofit profile at a glance
- EIN
- 541924721
- IRS 990-EZ coverage
- 2016–2025
- Forms available
- Form 990-EZ 2025
- Location
- Arlington, VA, USA
- Phone
- 7035493001
- Rating confidence
- Limited
- Sector
- Chambers of Commerce & Business Leagues
Reported finances
- Revenue
- $0
- Expenses
- $19,290
- Assets
- $215,227
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.
Leadership & pay
12 people listed
Executive titles in this filing
- Anne Cassity (Co-President)
- Chris Krese (Co-President)
People named in this filing
- Steven C Anderson (Co-Chairman)
- B Douglas Hoey (Co-Chairman)
- Anne Cassity (Co-President)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Ensure that Patients have continued access to affordable medication and prescription care from their Community Pharmacist.
What it reported doing in 2025
In 2006, the taxpayer began doing business as the Coalition for Community Pharmacy Action (CCPA). CCPA's mission is to ensure that patients have continued access to affordable medicines and prescription care from their trusted and accessible health professional-the community pharmacist. Activities have included public relations programs, research, grassroots efforts, advertising, and industry-related litigation.Taxpayer is jointly administered by the National Association of Chain Drug Stores, Inc. and the National Community Pharmacists Association.
Operating model
- Revenue model
- Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
- Distribution model
- Cannot be determined from the filing. The filing does not provide enough consistent spending detail to tell whether the nonprofit works directly or through others.
The verdict
- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.
Rating breakdown
- Financial Efficiency: NotEnoughData
- Transparency & Controls: 82
- Sustainability: 34
- Growth: 20
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: Limited
- Program expense ratio: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: Limited
- Total-asset coverage ratio: 11.16; rating input score 92; 92nd percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: -10.2% per year; rating input score 0; 24th percentile among comparable filings
- Asset growth: 26.4% per year; rating input score 100; 88th percentile among comparable filings
Details
- Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment
- Leadership: top reported pay $0 · 12 people listed
- Consistency: 5 of 5 current checks pass
- Schedules: 2 filed schedules
- Filing history: 9 filing years from 2016 to 2025
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- High — Growth: Revenue growth scored 0/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.